Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Baxter International
Baxter International
Baxter launches a new biotech with the Mayo Clinic in tow
Fierce Biotech
Mon, 06/1/15 - 07:10 pm
Baxter International
Mayo Clinic
Velocity Pharmaceuticals
Vitesse Biologics
Novo Nordisk rejects Baxter patent claim over Novoeight
Yahoo/Reuters
Wed, 05/20/15 - 06:19 pm
Novo Nordisk
Baxter International
NovoEight
Baxter looks to growth post-Baxalta spinout
Mass Device
Wed, 05/20/15 - 10:18 am
Baxter International
Baxalta
devices
Merrimack Pharmaceuticals and Baxter BioScience Announce Completion of New Drug Application Submission to U.S. FDA for MM-398 as a Treatment for Post-Gemcitabine Metastatic Pancreatic Cancer
Yahoo
Mon, 04/27/15 - 09:44 am
Merrimack Pharmaceuticals
Baxter International
MM-398
metastatic pancreatic cancer
Baxter's latest hemophilia drug comes through in Phase III
Fierce Biotech
Fri, 03/13/15 - 03:37 pm
Baxter International
hemophilia
BAX 817
Baxter backs away from vaccines with Vero tech sale to Nanotherapeutics
Fierce Vaccines
Mon, 12/15/14 - 06:56 pm
Baxter International
vaccines
M&A
Vero
Nanotherapeutics
Hot Drugmakers Build More Labs, Grab Space In Boston
Investors.com
Thu, 12/4/14 - 05:41 pm
Boston
Biogen Idec
Baxter International
Agios Pharmaceuticals
Pfizer
Pfizer closes $635M vaccines purchase from Baxter
Yahoo/AP
Mon, 12/1/14 - 04:42 pm
Pfizer
vaccines
M&A
Baxter International
Under siege by Biogen's new long-acting Eloctate, Baxter's Advate stands its ground
Fierce Pharma Marketing
Thu, 11/13/14 - 11:02 am
Biogen Idec
Elocate
Baxter International
Advate
FDA clears Baxter hemophilia A treatment
Seeking Alpha
Fri, 10/24/14 - 09:41 am
Baxter International
FDA
hemophilia A
Obizur
Baxter prepping for HyQvia launch with spinoff's success on the line
Fierce Pharma
Mon, 10/20/14 - 11:36 am
Baxter International
HyQvia
primary immunodeficiency
Medical products push Baxter profit above estimate
Yahoo/Reuters
Thu, 10/16/14 - 09:18 am
Baxter International
earnings
devices
Merrimack Does Well to License Marginal Cancer Drug to Baxter
TheStreet.com
Wed, 09/24/14 - 08:30 am
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Baxter International
Baxter and Halozyme sway the FDA after a painful rejection
Fierce Biotech
Mon, 09/15/14 - 11:46 am
Baxter International
Halozyme
FDA
HyQvia
Report: In a big split, Baxter looks to relocate biopharma to Boston
Fierce Biotech
Fri, 08/29/14 - 08:04 am
Baxter International
Boston
Long-acting version of Baxter's hemophilia drug succeeds in study
Yahoo/Reuters
Thu, 08/21/14 - 11:38 am
Baxter International
Advate
hemophilia A
BAX 855
The Positives and Negatives of Pfizer's $635 purchase of Baxter's Vaccines
Yahoo/Benzinga
Tue, 08/5/14 - 11:25 am
Pfizer
vaccines
M&A
Baxter International
FDA panel: Benefit of Baxter's immune therapy outweighs risk
Yahoo/Reuters
Thu, 07/31/14 - 04:03 pm
FDA
advisory panels
Baxter International
HyQvia
U.S. FDA panel reviews Baxter immune therapy's long-term safety
Yahoo/Reuters
Wed, 07/30/14 - 06:10 pm
FDA
Baxter International
HyQvia
Pfizer to buy Baxter’s vaccines for $635 million
Marketwatch
Wed, 07/30/14 - 08:50 am
Pfizer
Baxter International
vaccines
M&A
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »